NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

Delayed 10Q due to a German tax issue, Is it a cover for something substantial, not a few million research fund or operating loss incurred, but something like a deal in the making with German Merck-Merck KGaA.

Perhaps a licensing deal with Merck KGaA for Germany and/or whole Eu, excluding UK.
Perhaps a partnership deal with KGaA ...

All subjected to a peek at the results in about one month of time.

Judged by the unprecedentedly long delay, perhaps the underlined German tax issue is just an argot for a collaboration deal in the making?

[Note: Merck KGaA's glioblastoma candidate cilengitide failed in Ph III study treating GBM in early 2013]